GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the submission of the final module of the Premarket Approval (PMA) ...

The best ereaders for 2026

We tested ereaders from Kobo, Amazon, Boox and more to see which one is the best overall, along with a budget pick and the ...